Arcus biosciences to host conference call to discuss fourth-quarter and full-year 2023 financial results and pipeline updates

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will host a conference call and webcast on wednesday, february 21, 2024 at 2:00 pm pt / 5:00 pm et to discuss pipeline updates and details of the company's financial results for the quarter and year ended december 31st, 2023. investors interested in l.
RCUS Ratings Summary
RCUS Quant Ranking